skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8830

A review of topotecan in combination chemotherapy for advanced cervical cancer

Review

(2501) Views  (558) Full article downloads

Authors: Minoo Robati, David Holtz, Charles J Dunton

Published Date March 2008 Volume 2008:4(1) Pages 213 - 218
DOI: http://dx.doi.org/10.2147/TCRM.S1771

Minoo Robati, David Holtz, Charles J Dunton

Department of Obstetrics and Gynecology, Main Line Gynecologic Oncology, Lankenau Hospital, Wynnewood, PA, USA

Abstract: Treatment of advanced, recurrent or persistent cervical cancer includes radiotherapy and chemotherapy. Radiation has been the primary treatment modality for locoregionally advanced cervical cancer. Concomitant systemic cisplatin chemotherapy and radiation have shown high response rates with improvements in durable remissions and overall survival. Cisplatin has been the standard medication for the treatment of advanced cervical cancer. Combinations with other chemotherapeutic agents have been the subject of clinical trials with varying results. The toxicity of combination chemotherapy and tolerability of patients are other factors that should be considered in the management of patients with advanced disease. Recently topotecan, in combination with cisplatin, achieved increased response and overall survival rates without further compromising the patients’ quality of life. This review focuses on the mechanism of action and toxicities of topotecan, as well as its role as a radio-sensitizer and chemotherapeutic agent in the management of advanced, recurrent, or persistent cervical cancer. Other combination modalities and dosages are also discussed.

Keywords: topotecan, combination chemotherapy, advanced cervical cancer








Readers of this article also read:

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)
Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
Docetaxel for the post-surgery treatment of patients with node-positive breast cancer
"Globalized public health.” A transdisciplinary comprehensive framework for analyzing contemporary globalization’s influences on the field of public health
Multiple sclerosis: patients’ information sources and needs on disease symptoms and management
Hepatitis C virus infection and risk of cancer: a population-based cohort study
Dealing with grief related to loss by death and chronic pain: Suggestions for practice. Part 2
Clinical and economic considerations of antiobesity treatment: a review of orlistat
Subgroup analysis of large trials can guide further research: a case study of vitamin E and pneumonia
Erratum